177 related articles for article (PubMed ID: 25227434)
1. Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Ha YS; Lee GT; Kim YH; Kwon SY; Choi SH; Kim TH; Kwon TG; Yun SJ; Kim IY; Kim WJ
World J Surg Oncol; 2014 Sep; 12():288. PubMed ID: 25227434
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ
Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.
Waalkes S; Atschekzei F; Kramer MW; Hennenlotter J; Vetter G; Becker JU; Stenzl A; Merseburger AS; Schrader AJ; Kuczyk MA; Serth J
BMC Cancer; 2010 Sep; 10():503. PubMed ID: 20860816
[TBL] [Abstract][Full Text] [Related]
4. Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.
Vergho DC; Kneitz S; Kalogirou C; Burger M; Krebs M; Rosenwald A; Spahn M; Löser A; Kocot A; Riedmiller H; Kneitz B
PLoS One; 2014; 9(10):e109877. PubMed ID: 25279769
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
6. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.
Liu Y; Zhang C; Fan J; Xiao L; Yin B; Zhou L; Xia S
World J Surg Oncol; 2011 Oct; 9():121. PubMed ID: 21982273
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.
Betsunoh H; Fukuda T; Anzai N; Nishihara D; Mizuno T; Yuki H; Masuda A; Yamaguchi Y; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
BMC Cancer; 2013 Oct; 13():509. PubMed ID: 24168110
[TBL] [Abstract][Full Text] [Related]
11. Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Chen F; Chen C; Qu Y; Xiang H; Ai Q; Yang F; Tan X; Zhou Y; Jiang G; Zhang Z
Medicine (Baltimore); 2016 Aug; 95(35):e4592. PubMed ID: 27583873
[TBL] [Abstract][Full Text] [Related]
12. Tr-KIT/c-KIT ratio in renal cell carcinoma.
Ergün S; Altay DU; Güneş S; Büyükalpelli R; Karahan SC; Tomak L; Abur Ü
Mol Biol Rep; 2019 Oct; 46(5):5287-5294. PubMed ID: 31342295
[TBL] [Abstract][Full Text] [Related]
13. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
[TBL] [Abstract][Full Text] [Related]
14. Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma.
Qiao ZK; Li YL; Lu HT; Wang KL; Xu WH
World J Surg Oncol; 2013 Jan; 11():1. PubMed ID: 23281640
[TBL] [Abstract][Full Text] [Related]
15. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma.
Wu GL; Yuan JL; Huang XD; Rong JF; Zhang LX; Liu YP; Wang FL
Tumour Biol; 2013 Dec; 34(6):3431-5. PubMed ID: 23771851
[TBL] [Abstract][Full Text] [Related]
18. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
[TBL] [Abstract][Full Text] [Related]
19. Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.
Zhang S; Fang J; Zhang X; Qin C; Su S; Deng Y; Song Z; Zhang Y; Wang H; Yin C; Wang Z
Tumour Biol; 2014 Sep; 35(9):9095-100. PubMed ID: 25027395
[TBL] [Abstract][Full Text] [Related]
20. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]